nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP1A2—Carmustine—malignant glioma	0.368	0.57	CbGbCtD
Ranitidine—CYP3A4—Temozolomide—malignant glioma	0.278	0.43	CbGbCtD
Ranitidine—Nizatidine—BCHE—malignant glioma	0.0193	1	CrCbGaD
Ranitidine—SLC22A8—choroid plexus—malignant glioma	0.0183	0.581	CbGeAlD
Ranitidine—Nephrotoxicity—Carmustine—malignant glioma	0.0127	0.0757	CcSEcCtD
Ranitidine—Meningitis—Carmustine—malignant glioma	0.0104	0.0621	CcSEcCtD
Ranitidine—Nephropathy toxic—Carmustine—malignant glioma	0.00705	0.0419	CcSEcCtD
Ranitidine—Musculoskeletal pain—Temozolomide—malignant glioma	0.00396	0.0235	CcSEcCtD
Ranitidine—Aplastic anaemia—Temozolomide—malignant glioma	0.00368	0.0218	CcSEcCtD
Ranitidine—Gynaecomastia—Carmustine—malignant glioma	0.00362	0.0215	CcSEcCtD
Ranitidine—Hepatic failure—Temozolomide—malignant glioma	0.00316	0.0188	CcSEcCtD
Ranitidine—Breast disorder—Temozolomide—malignant glioma	0.00257	0.0153	CcSEcCtD
Ranitidine—Dysphagia—Carmustine—malignant glioma	0.00254	0.0151	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00251	0.0149	CcSEcCtD
Ranitidine—Dysphagia—Temozolomide—malignant glioma	0.00246	0.0146	CcSEcCtD
Ranitidine—Pancytopenia—Carmustine—malignant glioma	0.00241	0.0143	CcSEcCtD
Ranitidine—Neutropenia—Carmustine—malignant glioma	0.00238	0.0141	CcSEcCtD
Ranitidine—Pancytopenia—Temozolomide—malignant glioma	0.00233	0.0139	CcSEcCtD
Ranitidine—Neutropenia—Temozolomide—malignant glioma	0.0023	0.0136	CcSEcCtD
Ranitidine—Pneumonia—Carmustine—malignant glioma	0.00228	0.0135	CcSEcCtD
Ranitidine—Erectile dysfunction—Temozolomide—malignant glioma	0.00226	0.0134	CcSEcCtD
Ranitidine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00224	0.0133	CcSEcCtD
Ranitidine—Weight decreased—Temozolomide—malignant glioma	0.00222	0.0132	CcSEcCtD
Ranitidine—Pneumonia—Temozolomide—malignant glioma	0.0022	0.0131	CcSEcCtD
Ranitidine—Hallucination—Carmustine—malignant glioma	0.00202	0.012	CcSEcCtD
Ranitidine—Hepatitis—Temozolomide—malignant glioma	0.00197	0.0117	CcSEcCtD
Ranitidine—Hallucination—Temozolomide—malignant glioma	0.00196	0.0116	CcSEcCtD
Ranitidine—Erythema multiforme—Temozolomide—malignant glioma	0.00186	0.011	CcSEcCtD
Ranitidine—Arrhythmia—Carmustine—malignant glioma	0.00182	0.0108	CcSEcCtD
Ranitidine—Alopecia—Carmustine—malignant glioma	0.0018	0.0107	CcSEcCtD
Ranitidine—Erythema—Carmustine—malignant glioma	0.00177	0.0105	CcSEcCtD
Ranitidine—Alopecia—Temozolomide—malignant glioma	0.00174	0.0103	CcSEcCtD
Ranitidine—Erythema—Temozolomide—malignant glioma	0.00171	0.0102	CcSEcCtD
Ranitidine—Vision blurred—Carmustine—malignant glioma	0.00167	0.00991	CcSEcCtD
Ranitidine—Anaemia—Carmustine—malignant glioma	0.00164	0.00972	CcSEcCtD
Ranitidine—Agitation—Carmustine—malignant glioma	0.00163	0.00967	CcSEcCtD
Ranitidine—Vision blurred—Temozolomide—malignant glioma	0.00161	0.00958	CcSEcCtD
Ranitidine—Ill-defined disorder—Temozolomide—malignant glioma	0.00159	0.00943	CcSEcCtD
Ranitidine—Leukopenia—Carmustine—malignant glioma	0.00159	0.00941	CcSEcCtD
Ranitidine—Anaemia—Temozolomide—malignant glioma	0.00158	0.00939	CcSEcCtD
Ranitidine—Agitation—Temozolomide—malignant glioma	0.00157	0.00934	CcSEcCtD
Ranitidine—Angioedema—Temozolomide—malignant glioma	0.00156	0.00929	CcSEcCtD
Ranitidine—Malaise—Temozolomide—malignant glioma	0.00154	0.00917	CcSEcCtD
Ranitidine—Vertigo—Temozolomide—malignant glioma	0.00154	0.00913	CcSEcCtD
Ranitidine—Leukopenia—Temozolomide—malignant glioma	0.00153	0.0091	CcSEcCtD
Ranitidine—Chest pain—Carmustine—malignant glioma	0.00151	0.00895	CcSEcCtD
Ranitidine—Myalgia—Carmustine—malignant glioma	0.00151	0.00895	CcSEcCtD
Ranitidine—Confusional state—Carmustine—malignant glioma	0.00146	0.00865	CcSEcCtD
Ranitidine—Myalgia—Temozolomide—malignant glioma	0.00146	0.00865	CcSEcCtD
Ranitidine—Arthralgia—Temozolomide—malignant glioma	0.00146	0.00865	CcSEcCtD
Ranitidine—Discomfort—Temozolomide—malignant glioma	0.00144	0.00855	CcSEcCtD
Ranitidine—Thrombocytopenia—Carmustine—malignant glioma	0.00142	0.0084	CcSEcCtD
Ranitidine—Tachycardia—Carmustine—malignant glioma	0.00141	0.00838	CcSEcCtD
Ranitidine—Confusional state—Temozolomide—malignant glioma	0.00141	0.00836	CcSEcCtD
Ranitidine—SLC22A1—telencephalon—malignant glioma	0.0014	0.0445	CbGeAlD
Ranitidine—Anaphylactic shock—Temozolomide—malignant glioma	0.0014	0.00829	CcSEcCtD
Ranitidine—Thrombocytopenia—Temozolomide—malignant glioma	0.00137	0.00812	CcSEcCtD
Ranitidine—Hypotension—Carmustine—malignant glioma	0.00135	0.00802	CcSEcCtD
Ranitidine—Hyperhidrosis—Temozolomide—malignant glioma	0.00135	0.00802	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00132	0.00782	CcSEcCtD
Ranitidine—Insomnia—Carmustine—malignant glioma	0.00131	0.00776	CcSEcCtD
Ranitidine—Dyspnoea—Carmustine—malignant glioma	0.00129	0.00765	CcSEcCtD
Ranitidine—Somnolence—Carmustine—malignant glioma	0.00128	0.00763	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00127	0.00756	CcSEcCtD
Ranitidine—Insomnia—Temozolomide—malignant glioma	0.00126	0.0075	CcSEcCtD
Ranitidine—Dyspnoea—Temozolomide—malignant glioma	0.00125	0.0074	CcSEcCtD
Ranitidine—Somnolence—Temozolomide—malignant glioma	0.00124	0.00737	CcSEcCtD
Ranitidine—Pain—Carmustine—malignant glioma	0.00124	0.00734	CcSEcCtD
Ranitidine—Constipation—Carmustine—malignant glioma	0.00124	0.00734	CcSEcCtD
Ranitidine—HRH2—central nervous system—malignant glioma	0.00124	0.0392	CbGeAlD
Ranitidine—Constipation—Temozolomide—malignant glioma	0.00119	0.00709	CcSEcCtD
Ranitidine—Pain—Temozolomide—malignant glioma	0.00119	0.00709	CcSEcCtD
Ranitidine—Feeling abnormal—Carmustine—malignant glioma	0.00119	0.00707	CcSEcCtD
Ranitidine—Feeling abnormal—Temozolomide—malignant glioma	0.00115	0.00684	CcSEcCtD
Ranitidine—Body temperature increased—Carmustine—malignant glioma	0.00114	0.00679	CcSEcCtD
Ranitidine—Abdominal pain—Carmustine—malignant glioma	0.00114	0.00679	CcSEcCtD
Ranitidine—Urticaria—Temozolomide—malignant glioma	0.00111	0.00659	CcSEcCtD
Ranitidine—Abdominal pain—Temozolomide—malignant glioma	0.0011	0.00656	CcSEcCtD
Ranitidine—Body temperature increased—Temozolomide—malignant glioma	0.0011	0.00656	CcSEcCtD
Ranitidine—Hypersensitivity—Carmustine—malignant glioma	0.00106	0.00632	CcSEcCtD
Ranitidine—Hypersensitivity—Temozolomide—malignant glioma	0.00103	0.00611	CcSEcCtD
Ranitidine—Diarrhoea—Carmustine—malignant glioma	0.000989	0.00587	CcSEcCtD
Ranitidine—Pruritus—Temozolomide—malignant glioma	0.000988	0.00587	CcSEcCtD
Ranitidine—HRH2—brain—malignant glioma	0.000981	0.0312	CbGeAlD
Ranitidine—Dizziness—Carmustine—malignant glioma	0.000956	0.00568	CcSEcCtD
Ranitidine—Diarrhoea—Temozolomide—malignant glioma	0.000956	0.00568	CcSEcCtD
Ranitidine—ABCB1—blood vessel—malignant glioma	0.000931	0.0296	CbGeAlD
Ranitidine—Dizziness—Temozolomide—malignant glioma	0.000924	0.00549	CcSEcCtD
Ranitidine—Vomiting—Carmustine—malignant glioma	0.000919	0.00546	CcSEcCtD
Ranitidine—Rash—Carmustine—malignant glioma	0.000911	0.00541	CcSEcCtD
Ranitidine—Dermatitis—Carmustine—malignant glioma	0.00091	0.00541	CcSEcCtD
Ranitidine—Headache—Carmustine—malignant glioma	0.000905	0.00538	CcSEcCtD
Ranitidine—Vomiting—Temozolomide—malignant glioma	0.000888	0.00527	CcSEcCtD
Ranitidine—Rash—Temozolomide—malignant glioma	0.000881	0.00523	CcSEcCtD
Ranitidine—Dermatitis—Temozolomide—malignant glioma	0.00088	0.00523	CcSEcCtD
Ranitidine—Headache—Temozolomide—malignant glioma	0.000875	0.0052	CcSEcCtD
Ranitidine—Nausea—Carmustine—malignant glioma	0.000858	0.0051	CcSEcCtD
Ranitidine—Nausea—Temozolomide—malignant glioma	0.00083	0.00493	CcSEcCtD
Ranitidine—SLC22A1—central nervous system—malignant glioma	0.000796	0.0253	CbGeAlD
Ranitidine—SLC22A8—central nervous system—malignant glioma	0.000731	0.0232	CbGeAlD
Ranitidine—CYP2D6—brainstem—malignant glioma	0.000707	0.0225	CbGeAlD
Ranitidine—SLC22A1—brain—malignant glioma	0.000632	0.0201	CbGeAlD
Ranitidine—CYP2D6—telencephalon—malignant glioma	0.000628	0.0199	CbGeAlD
Ranitidine—SLC22A8—brain—malignant glioma	0.000581	0.0185	CbGeAlD
Ranitidine—ABCB1—embryo—malignant glioma	0.000555	0.0176	CbGeAlD
Ranitidine—ABCB1—retina—malignant glioma	0.000491	0.0156	CbGeAlD
Ranitidine—ABCB1—telencephalon—malignant glioma	0.000451	0.0143	CbGeAlD
Ranitidine—CYP3A4—central nervous system—malignant glioma	0.000363	0.0115	CbGeAlD
Ranitidine—CYP2D6—central nervous system—malignant glioma	0.000357	0.0113	CbGeAlD
Ranitidine—ABCB1—medulla oblongata—malignant glioma	0.000355	0.0113	CbGeAlD
Ranitidine—CYP2D6—cerebellum—malignant glioma	0.000349	0.0111	CbGeAlD
Ranitidine—ABCB1—midbrain—malignant glioma	0.000324	0.0103	CbGeAlD
Ranitidine—ABCB1—spinal cord—malignant glioma	0.000316	0.0101	CbGeAlD
Ranitidine—CYP2D6—brain—malignant glioma	0.000283	0.009	CbGeAlD
Ranitidine—ABCB1—central nervous system—malignant glioma	0.000257	0.00815	CbGeAlD
Ranitidine—ABCB1—cerebellum—malignant glioma	0.000251	0.00797	CbGeAlD
Ranitidine—ABCB1—brain—malignant glioma	0.000204	0.00647	CbGeAlD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	6.68e-05	0.000498	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ASMT—malignant glioma	6.68e-05	0.000498	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	6.68e-05	0.000498	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	6.66e-05	0.000496	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AKT2—malignant glioma	6.63e-05	0.000494	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NTRK1—malignant glioma	6.59e-05	0.000491	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	6.59e-05	0.000491	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	6.44e-05	0.00048	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—BCAN—malignant glioma	6.43e-05	0.00048	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CD—malignant glioma	6.37e-05	0.000474	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP2B6—malignant glioma	6.31e-05	0.00047	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ASMT—malignant glioma	6.29e-05	0.000469	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—BCAN—malignant glioma	6.28e-05	0.000468	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—COX8A—malignant glioma	6.27e-05	0.000467	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.13e-05	0.000457	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP3—malignant glioma	6.13e-05	0.000457	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PIK3CB—malignant glioma	6.11e-05	0.000455	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN2B—malignant glioma	6.07e-05	0.000453	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	5.98e-05	0.000446	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—BCAN—malignant glioma	5.92e-05	0.000441	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTK2—malignant glioma	5.9e-05	0.00044	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCL8—malignant glioma	5.87e-05	0.000438	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.84e-05	0.000435	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HES1—malignant glioma	5.79e-05	0.000432	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—IDH1—malignant glioma	5.77e-05	0.00043	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NCOR1—malignant glioma	5.76e-05	0.000429	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTT1—malignant glioma	5.69e-05	0.000424	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—RAF1—malignant glioma	5.68e-05	0.000424	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	5.62e-05	0.000419	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—IL2—malignant glioma	5.61e-05	0.000418	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.61e-05	0.000418	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—SPHK1—malignant glioma	5.58e-05	0.000416	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CB—malignant glioma	5.55e-05	0.000414	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PDGFRA—malignant glioma	5.52e-05	0.000411	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP2C18—malignant glioma	5.47e-05	0.000408	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SPP1—malignant glioma	5.36e-05	0.000399	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS1—malignant glioma	5.34e-05	0.000398	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ASMT—malignant glioma	5.33e-05	0.000397	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCL8—malignant glioma	5.33e-05	0.000397	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.21e-05	0.000388	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—IDH2—malignant glioma	5.19e-05	0.000387	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL2—malignant glioma	5.1e-05	0.00038	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TERT—malignant glioma	5.08e-05	0.000378	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.08e-05	0.000378	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—IDH2—malignant glioma	5.06e-05	0.000377	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—BCAN—malignant glioma	5.01e-05	0.000374	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—BCHE—malignant glioma	4.96e-05	0.00037	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PDGFB—malignant glioma	4.96e-05	0.000369	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FGFR1—malignant glioma	4.93e-05	0.000367	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—SLC5A5—malignant glioma	4.9e-05	0.000365	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.89e-05	0.000364	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP2B6—malignant glioma	4.88e-05	0.000363	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HIF1A—malignant glioma	4.86e-05	0.000362	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—COX8A—malignant glioma	4.84e-05	0.000361	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—IDH2—malignant glioma	4.77e-05	0.000355	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP2B6—malignant glioma	4.76e-05	0.000355	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CAV1—malignant glioma	4.7e-05	0.00035	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.67e-05	0.000348	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KDR—malignant glioma	4.64e-05	0.000346	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.57e-05	0.00034	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.51e-05	0.000336	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP2B6—malignant glioma	4.48e-05	0.000334	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FN1—malignant glioma	4.47e-05	0.000333	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—F2—malignant glioma	4.47e-05	0.000333	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—IDH1—malignant glioma	4.46e-05	0.000332	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTT1—malignant glioma	4.42e-05	0.00033	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—BAD—malignant glioma	4.42e-05	0.000329	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NOTCH1—malignant glioma	4.37e-05	0.000326	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—IDH1—malignant glioma	4.35e-05	0.000324	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.35e-05	0.000324	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.32e-05	0.000322	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—SPHK1—malignant glioma	4.32e-05	0.000322	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CD80—malignant glioma	4.29e-05	0.000319	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—APC—malignant glioma	4.28e-05	0.000319	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CG—malignant glioma	4.28e-05	0.000319	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGF—malignant glioma	4.23e-05	0.000315	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP2C18—malignant glioma	4.23e-05	0.000315	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—SPHK1—malignant glioma	4.21e-05	0.000314	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTPN11—malignant glioma	4.2e-05	0.000313	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS1—malignant glioma	4.14e-05	0.000309	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP2C18—malignant glioma	4.13e-05	0.000308	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ASMT—malignant glioma	4.12e-05	0.000307	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—IDH1—malignant glioma	4.1e-05	0.000306	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—IDH2—malignant glioma	4.04e-05	0.000301	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—BRAF—malignant glioma	4.02e-05	0.0003	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.99e-05	0.000297	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SPHK1—malignant glioma	3.97e-05	0.000296	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.96e-05	0.000295	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTP1—malignant glioma	3.95e-05	0.000294	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AKT2—malignant glioma	3.91e-05	0.000292	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EGFR—malignant glioma	3.9e-05	0.00029	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP2C18—malignant glioma	3.89e-05	0.00029	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—BCAN—malignant glioma	3.87e-05	0.000288	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—BCHE—malignant glioma	3.85e-05	0.000287	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CAT—malignant glioma	3.84e-05	0.000286	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.84e-05	0.000286	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.81e-05	0.000284	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—SLC5A5—malignant glioma	3.81e-05	0.000284	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.8e-05	0.000283	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CD—malignant glioma	3.76e-05	0.00028	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PIK3CA—malignant glioma	3.72e-05	0.000278	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—KRAS—malignant glioma	3.68e-05	0.000274	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.63e-05	0.000271	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NCOR1—malignant glioma	3.63e-05	0.00027	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FGF2—malignant glioma	3.6e-05	0.000268	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.5e-05	0.000261	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—IDH1—malignant glioma	3.47e-05	0.000259	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTT1—malignant glioma	3.42e-05	0.000255	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CA—malignant glioma	3.38e-05	0.000252	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MDM2—malignant glioma	3.37e-05	0.000251	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SPHK1—malignant glioma	3.36e-05	0.000251	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RAF1—malignant glioma	3.36e-05	0.00025	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTT1—malignant glioma	3.34e-05	0.000249	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ERBB2—malignant glioma	3.32e-05	0.000248	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.29e-05	0.000246	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CB—malignant glioma	3.28e-05	0.000244	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.24e-05	0.000241	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS1—malignant glioma	3.2e-05	0.000239	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.19e-05	0.000238	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL8—malignant glioma	3.15e-05	0.000235	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTT1—malignant glioma	3.14e-05	0.000234	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS1—malignant glioma	3.13e-05	0.000233	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—IDH2—malignant glioma	3.12e-05	0.000232	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.11e-05	0.000232	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTP1—malignant glioma	3.07e-05	0.000228	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—AKT1—malignant glioma	3.04e-05	0.000227	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CASP3—malignant glioma	3.01e-05	0.000225	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2—malignant glioma	3.01e-05	0.000224	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CAT—malignant glioma	2.98e-05	0.000222	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—BCHE—malignant glioma	2.98e-05	0.000222	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CAV1—malignant glioma	2.96e-05	0.00022	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS1—malignant glioma	2.95e-05	0.00022	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.94e-05	0.000219	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.93e-05	0.000219	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—BCHE—malignant glioma	2.91e-05	0.000217	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—SLC5A5—malignant glioma	2.87e-05	0.000214	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP9—malignant glioma	2.85e-05	0.000212	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTEN—malignant glioma	2.83e-05	0.000211	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.83e-05	0.000211	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NCOR1—malignant glioma	2.82e-05	0.00021	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.78e-05	0.000207	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AKT1—malignant glioma	2.76e-05	0.000206	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.76e-05	0.000205	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—BCHE—malignant glioma	2.74e-05	0.000204	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.73e-05	0.000204	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.71e-05	0.000202	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CG—malignant glioma	2.69e-05	0.000201	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—IDH1—malignant glioma	2.68e-05	0.0002	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTT1—malignant glioma	2.66e-05	0.000199	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.64e-05	0.000197	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PPARG—malignant glioma	2.6e-05	0.000194	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SPHK1—malignant glioma	2.59e-05	0.000193	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—malignant glioma	2.56e-05	0.000191	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.54e-05	0.000189	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—malignant glioma	2.53e-05	0.000189	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS1—malignant glioma	2.5e-05	0.000186	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.49e-05	0.000185	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.4e-05	0.000179	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTP1—malignant glioma	2.37e-05	0.000177	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CD—malignant glioma	2.37e-05	0.000176	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—malignant glioma	2.35e-05	0.000175	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—BCHE—malignant glioma	2.32e-05	0.000173	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTP1—malignant glioma	2.31e-05	0.000172	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CAT—malignant glioma	2.31e-05	0.000172	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—malignant glioma	2.3e-05	0.000172	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CAV1—malignant glioma	2.3e-05	0.000171	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.29e-05	0.000171	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CAT—malignant glioma	2.25e-05	0.000168	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTP1—malignant glioma	2.18e-05	0.000162	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NCOR1—malignant glioma	2.18e-05	0.000162	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KRAS—malignant glioma	2.17e-05	0.000162	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.17e-05	0.000162	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.15e-05	0.00016	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NCOR1—malignant glioma	2.13e-05	0.000158	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CAT—malignant glioma	2.12e-05	0.000158	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.09e-05	0.000156	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CB—malignant glioma	2.06e-05	0.000154	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTT1—malignant glioma	2.06e-05	0.000153	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—malignant glioma	2.04e-05	0.000152	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PPARG—malignant glioma	2.02e-05	0.00015	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NCOR1—malignant glioma	2e-05	0.000149	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CA—malignant glioma	2e-05	0.000149	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—malignant glioma	1.93e-05	0.000144	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS1—malignant glioma	1.93e-05	0.000144	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.87e-05	0.00014	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTP1—malignant glioma	1.85e-05	0.000138	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.84e-05	0.000137	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CAT—malignant glioma	1.8e-05	0.000134	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—BCHE—malignant glioma	1.79e-05	0.000133	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTEN—malignant glioma	1.78e-05	0.000133	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CAV1—malignant glioma	1.78e-05	0.000132	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.77e-05	0.000132	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CAV1—malignant glioma	1.73e-05	0.000129	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOR1—malignant glioma	1.7e-05	0.000126	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.7e-05	0.000126	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CAV1—malignant glioma	1.63e-05	0.000122	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AKT1—malignant glioma	1.63e-05	0.000122	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.62e-05	0.000121	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.6e-05	0.000119	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—malignant glioma	1.59e-05	0.000118	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CG—malignant glioma	1.58e-05	0.000118	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PPARG—malignant glioma	1.56e-05	0.000116	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PPARG—malignant glioma	1.52e-05	0.000114	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.49e-05	0.000111	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PPARG—malignant glioma	1.44e-05	0.000107	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTP1—malignant glioma	1.43e-05	0.000106	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.42e-05	0.000106	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CD—malignant glioma	1.39e-05	0.000103	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CAT—malignant glioma	1.39e-05	0.000103	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTEN—malignant glioma	1.39e-05	0.000103	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CAV1—malignant glioma	1.38e-05	0.000103	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.32e-05	9.85e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.31e-05	9.76e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.31e-05	9.75e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.26e-05	9.39e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CA—malignant glioma	1.26e-05	9.38e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.24e-05	9.24e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—malignant glioma	1.23e-05	9.15e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PPARG—malignant glioma	1.22e-05	9.06e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CB—malignant glioma	1.21e-05	9.01e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—malignant glioma	1.2e-05	8.93e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.14e-05	8.49e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—malignant glioma	1.13e-05	8.42e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.11e-05	8.26e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTEN—malignant glioma	1.07e-05	7.98e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CAV1—malignant glioma	1.07e-05	7.96e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTEN—malignant glioma	1.05e-05	7.79e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—AKT1—malignant glioma	1.03e-05	7.66e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTEN—malignant glioma	9.85e-06	7.34e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CA—malignant glioma	9.77e-06	7.28e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CG—malignant glioma	9.72e-06	7.25e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CB—malignant glioma	9.66e-06	7.2e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—malignant glioma	9.57e-06	7.13e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PPARG—malignant glioma	9.39e-06	7e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CD—malignant glioma	8.55e-06	6.37e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTEN—malignant glioma	8.34e-06	6.22e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—AKT1—malignant glioma	7.98e-06	5.95e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CA—malignant glioma	7.55e-06	5.63e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CB—malignant glioma	7.45e-06	5.55e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—malignant glioma	7.38e-06	5.5e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CA—malignant glioma	7.37e-06	5.49e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CA—malignant glioma	6.95e-06	5.18e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTEN—malignant glioma	6.44e-06	4.8e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—AKT1—malignant glioma	6.17e-06	4.6e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—AKT1—malignant glioma	6.02e-06	4.49e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.89e-06	4.39e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—AKT1—malignant glioma	5.68e-06	4.23e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKT1—malignant glioma	4.81e-06	3.58e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.54e-06	3.39e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKT1—malignant glioma	3.71e-06	2.77e-05	CbGpPWpGaD
